Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Marginal Zone B Cells Facilitate RBC Alloimmunization Independent of Direct CD4 + T Cell Activation

Patricia E Zerra, MD, Seema R Patel, BS, PhD, Ashley L Bennett, BA, Sean R Stowell, MD PhD

Blood (2017) 130 (Supplement 1): 2399.

https://doi.org/10.1182/blood.V130.Suppl_1.2399.2399

Published: 2017

Journal Articles

Utility of Fluorescence Cytometric Cross-Matched Platelets in Severely Alloimmunized Patients

Krishna P Joshi, MBBS, MD, Soumya Pandey, MD, Bobbie Shirlonda Rhodes-Clark, MS, Gina Drobena, MD, Terry O Harville, Muthu Kumaran Veeraputhiran, MD MPH

Blood (2016) 128 (22): 3858.

https://doi.org/10.1182/blood.V128.22.3858.3858

Published: 2016

Journal Articles

Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia

Vera Magistroni, PhD, Nitesh Sharma, Rocco Piazza, MD, PhD, Jason G Harb, Ph.D, Roberta Spinelli, M.Sc., Alessandra Pirola, M.Sc., Justin Ellis, Kim Dong-Wook, Danilo Perrotti, MD, Ph.D, Carlo Gambacorti-Passerini, MD

Blood (2012) 120 (21): 3727.

https://doi.org/10.1182/blood.V120.21.3727.3727

Published: 2012

Journal Articles

An Approach to the “Untransfusable” Patient

Gemma Louise Crighton, MD, Philip A Thompson, MD, Mary Gaskell, Marija Borosak, FRCPA, FRACP, MBBS, Anne C Dykes, MD, FRACP, FRCPA, Jennifer Condon, Scott McArdle, Merrole Faye Cole-Sinclair

Blood (2012) 120 (21): 4385.

https://doi.org/10.1182/blood.V120.21.4385.4385

Published: 2012

Journal Articles

Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients,

Rocco Piazza, MD, PhD, Simona Valletta, M.Sc., Alessandra Pirola, M.Sc., Hima Raman, M.Sc., Roberta Spinelli, M.Sc., Nick C.P. Cross, PhD, Caterina Cecchetti, MD, Zaira Sortino, B.Sc., Carlo Gambacorti-Passerini, MD

Blood (2011) 118 (21): 3853.

https://doi.org/10.1182/blood.V118.21.3853.3853

Published: 2011

Journal Articles

CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis

Carlo Gambacorti-Passerini, MD, Simona Valletta, M.Sc., Alessandra Stasia, MD, Alexander Leeksma, Nitesh Sharma, Christian Rizzo, Enrico Maria Pogliani, MD, Alessandra Pirola, M.Sc., Rocco Piazza, MD, PhD

Blood (2011) 118 (21): 2739.

https://doi.org/10.1182/blood.V118.21.2739.2739

Published: 2011

Journal Articles

A Transfusion Audit In An Ugandan Hospital

Heather A Hume, MD, FRCPC, Henry Ddungu, MD, Amos Odiit, MD, Susan Nabadda Ndidde, MD

Blood (2010) 116 (21): 4410.

https://doi.org/10.1182/blood.V116.21.4410.4410

Published: 2010

Journal Articles

Costimulatory Blockade Enhances Engraftment and Prevents Anti-Donor Antibody Generation in Nonmyeloablative Conditioned Prediabetic NOD Mice

Larry D Bozulic, Ph.D, Hong Xu, M.D., Yiming Huang, M.D., Suzanne T Ildstad, M.D.

Blood (2008) 112 (11): 4597.

https://doi.org/10.1182/blood.V112.11.4597.4597

Published: 2008

Journal Articles

Phase 1 Clinical Trial of Prion-Filtered Red Cell Concentrates (pfRCC) in Patients Requiring Allogeneic Blood Transfusion.

Tracy Murphy, Mary R Cahill, Jim Fagan, Croxon Harry, Mohammed Khan, Oonagh Gilligan, Stephen McGrath, William G Murphy

Blood (2008) 112 (11): 994.

https://doi.org/10.1182/blood.V112.11.994.994

Published: 2008

Journal Articles

CD154:CD40 Co-Stimulatory Blockade: A Specific Approach To Prevent Sensitization to Donor Alloantigens.

Hong Xu, MD, Jun Yan, MD, PhD, Suzanne T. Ildstad, MD

Blood (2007) 110 (11): 2246.

https://doi.org/10.1182/blood.V110.11.2246.2246

Published: 2007

Journal Articles

Human Mesenchymal Stem Cells Inhibit In Vitro Antibody Production Against Alloantigens.

Patrizia Comoli, MD, Rita Maccario, PhD, Maria Antonietta Avanzini, PhD, Fabrizio Ginevri, MD, Antonia Moretta, PhD, Marina Podestà, PhD, Massimo Marconi, PhD, Angela Cometa, BSci, Maria Ester Bernardo, MD, Francesco Frassoni, MD, Franco Locatelli, MD, PhD

Blood (2005) 106 (11): 3033.

https://doi.org/10.1182/blood.V106.11.3033.3033

Published: 2005

Journal Articles

CD154:CD40 Co-Stimulatory Blockade: A Novel Approach To Prevent Sensitization to Donor Alloantigens.

Hong Xu, MD, Jun Yan, MD, PhD, Suzanne T. Ildstad, MD

Blood (2005) 106 (11): 1273.

https://doi.org/10.1182/blood.V106.11.1273.1273

Published: 2005

NARROW

Marginal Zone B Cells Facilitate RBC Alloimmunization Independent of Direct CD4 + T Cell Activation

Utility of Fluorescence Cytometric Cross-Matched Platelets in Severely Alloimmunized Patients

Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia

An Approach to the “Untransfusable” Patient

Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients,

CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis

A Transfusion Audit In An Ugandan Hospital

Costimulatory Blockade Enhances Engraftment and Prevents Anti-Donor Antibody Generation in Nonmyeloablative Conditioned Prediabetic NOD Mice

Phase 1 Clinical Trial of Prion-Filtered Red Cell Concentrates (pfRCC) in Patients Requiring Allogeneic Blood Transfusion.

CD154:CD40 Co-Stimulatory Blockade: A Specific Approach To Prevent Sensitization to Donor Alloantigens.

Human Mesenchymal Stem Cells Inhibit In Vitro Antibody Production Against Alloantigens.

CD154:CD40 Co-Stimulatory Blockade: A Novel Approach To Prevent Sensitization to Donor Alloantigens.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only